← Back to Fund Radar
HIK.L

HIKMA PHARMACEUTICAL

GB00B0LCW083 · HIK.L (LSE)

0 value funds · 5 CNMV managers

1-year price history

Source: Yahoo Finance
- Calculating change...

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded.

Value funds holding it
0

Of the value funds we track closely. A different universe and period from "CNMV managers": never added together.

See in Radar Fondos →
Funds (CNMV universe)
7

9 → 7 (-2) · net presence change vs. previous period

Avg. weight
0.71%
Price
1662.00 GBp
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

CNMV data · half-year closed 2025-12-31.

Price for HIK.L (LSE), updated 2026-10-18. Source: Yahoo Finance.

Funds holding this company

CNMV period H2 2025. Weight is the sum of every instrument of the company that fund holds (local share, ADR or another class), not just one.

Company-level moves

Compares H1 2025 with H2 2025, summing every instrument of the company each fund holds. A fund switching instrument within the same company doesn't show up here as an entry or exit — for that instrument-by-instrument detail, see the Instruments section.

New positions: 2 Exits: 4 Increasing exposure: 1 Reducing exposure: 1
+ RENTA 4 ALPHA GLOBAL, FI

Enters the position at 0.30% weight.

+ GVC GAESCO CROSSOVER, FI

Enters the position at 0.04% weight.

− BELGRAVIA DELTA,FI

Leaves the position; it weighed 1.16%.

− BELGRAVIA EPSILON, FI

Leaves the position; it weighed 1.25%.

− BELGRAVIA VALUE STRATEGY, FI

Leaves the position; it weighed 2.10%.

− COMPROMISO MEDIOLANUM, FI

Leaves the position; it weighed 0.12%.

Objective ratios

FCF yield
0.4%
Net debt / EBITDA
1.90x
P/E
—
52-week range
1187.00 – 1865.00 GBp

Data as-is, not an interpretation: it does not say whether the price is cheap or expensive, and it is not a buy or sell recommendation.

Updated 2026-09-06. Source: Yahoo Finance.

Disclaimer

This is not financial advice. Weights come from the periodic reports each manager files with the CNMV and lag the real close of the period. Price, description and ratios, when available, come from Yahoo Finance and may not exactly match this ISIN if the company has multiple share classes.